The FDA has removed indications that Niaspan and Trilipix should be used with statin cholesterol drugs and has also withdrawn approval for the marketing and sale of Advicor and Simcor…
Doctors frequently prescribe cholesterol-fighting drugs that may carry a risk of significant side effects, even though there is limited evidence that the drugs will help their patients, according to the…
Researchers indicate that despite an increased risk of acquiring type 2 diabetes from statin medications, such as Crestor and Lipitor, the benefits of the cholesterol-reducing drugs still outweigh any known…
Federal health regulators are warning that cholesterol lowering drugs like Lipitor, Crestor and Zocor could increase the risk of diabetes, muscle injury and could cause cognitive impairments like memory loss…
